Table 1.
Demographics | N = 42 Subjects |
---|---|
Female, No. (%) | 23/42 (54.7) |
Age, mean (SD), y n = 42 | 68.89 (11.8) |
BMI, mean (SD), Kg/m2 n = 42 | 27.14(5.6) |
Chronic lung disease (COPD/ILD/Asthma) No. (%) | 26/42 (61.9) |
History of cancer No. (%) | 19/42 (45.2) |
History of lung cancer No. (%) | 3/42 (7) |
Smoking history No. (%) | 31/42 (73.8) |
Lesion Properties | |
Median Nodule size (mm) n = 42 (IQR) | 12 (10–18) |
FDG avid No. (%) | 27/32 84.4% |
Median SUV if FDG avid (mm) n = 27 (IQR) | 4 (2.1–6.7) |
Bronchus sign, No. (%) | 25/42 (59.2) |
Nodule location, No. (%) | |
Right upper lobe | 19/42 (45.2) |
Left upper lobe | 10 /42(23.8) |
Right middle lobe | 4/42 (9.5) |
Right lower lobe | 6/42 (14.3) |
Left lower lobe | 3/42 (7.1) |
Lesion in central third of the lung | 12/42 (28.6) |
Lesion in middle third of the lung | 20/42 (47.6) |
Lesion in outer third of the lung | 10/42 (23.8) |
Nodule Radiologic features No. (%) | |
Solid | 37/42 (88) |
Semi Solid | 2/42 (4.8) |
Ground glass | 3/42 (7.1) |
Spiculated lesion border | 10 /42 (23.8) |
Procedure characteristics | |
General anesthesia | 42 (100%) |
Radial EBUS used during ENB | 42 (100%) |
Endobronchial ultrasound (EBUS-TBNA) No. (%) | 23/40 (57.5) |
Bronchioalveolar lavage No. (%) | |
+Malignancy | 4/42 (9.5%) |
+Infection Fungi | 2/42 (4.7) |
Negative (normal cellular analysis) | 36/42 (85%) |
Fluoroscopy used during ENB | 42 (100%) |
ROSE used | 42 (100%) |
Median number of passes (mm) n = 35 (IQR) | 10 (7–2) |
Data are presented as % (n/N), median (interquartile range), or mean (standard deviation). EBUS, endobronchial ultrasound. ENB electromagnetic navigation bronchoscopy. EBUS-TBNA, endobronchial ultrasound-guided transbronchial fine needle aspiration. ROSE, rapid on-site evaluation.